% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Hillengass:120390,
author = {J. Hillengass$^*$ and M.-A. Weber$^*$ and K. Kilk and K.
Listl and B. Wagner-Gund$^*$ and M. Hillengass and T.
Hielscher$^*$ and A. Farid and K. Neben and S. Delorme$^*$
and O. Landgren and H. Goldschmidt$^*$},
title = {{P}rognostic significance of whole-body {MRI} in patients
with monoclonal gammopathy of undetermined significance.},
journal = {Leukemia},
volume = {28},
number = {1},
issn = {1476-5551},
address = {Basingstoke},
publisher = {Nature Publ. Group},
reportid = {DKFZ-2017-00823},
pages = {174 - 178},
year = {2014},
abstract = {Radiological skeletal survey or computed tomography are
currently applied to assess bone diseases in patients with
monoclonal plasma cell disorders. Whole-body magnetic
resonance imaging (whole-body MRI) allows detecting the
infiltration of clonal cells in nearly the whole bone marrow
compartment even before bone destruction has occurred. Those
MRI results (i.e., patterns of bone marrow infiltration)
have been demonstrated to be of prognostic significance in
patients with symptomatic as well as asymptomatic multiple
myeloma. We have therefore analyzed the findings of
whole-body MRI in 137 consecutive individuals with
monoclonal gammopathy of undetermined significance (MGUS). A
focal infiltration pattern was detected in $23.4\%$ of
patients. Presence and number of focal lesions as well as
value of M-Protein were of independent prognostic
significance for progression into a symptomatic disease
requiring systemic treatment (P=0.02; P<0.0001 and P=0.0005,
respectively). Lower homogeneous signal intensities in
T1-weighted images were related to a physiologically higher
bone marrow cellularity in younger individuals (P=0.002). We
conclude that whole-body MRI identifies patients with focal
accumulations of presumably monoclonal cells in bone marrow
with prognostic impact concerning the risk of progression
into symptomatic disease.},
cin = {E013 / E010 / C060},
ddc = {610},
cid = {I:(DE-He78)E013-20160331 / I:(DE-He78)E010-20160331 /
I:(DE-He78)C060-20160331},
pnm = {315 - Imaging and radiooncology (POF3-315)},
pid = {G:(DE-HGF)POF3-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:23958921},
doi = {10.1038/leu.2013.244},
url = {https://inrepo02.dkfz.de/record/120390},
}